Skip to Main Content

MIMIC

Built at Built with Claude: Life Sciences · Jul 7, 2026 · Remote

MIMIC — Demo video

We carry ~100x more microbial genes than human genes (~3.3M vs ~20,000), and we already know microbes signal to us in chemistry — SCFAs->GPR43, bile acids->FXR/TGR5, tryptophan->AhR, some even mimicking our own ligands (Cohen 2017). The open question is the secreted proteins: do microbes also signal in protein, and we've simply never looked? We built a structure-first screen to find out. The pipeline, one candidate. Starting from 965 million GMSC smORFs across 75 habitats, four filters narrow to 2,187 gut-only secreted family representatives, then a signal-peptide-aware mature-form refold collapses to 297 mature families. Each was co-folded against 25 targets — 15 human immune/cytokine/GPCR/barrier receptors plus 10 fold-matched decoys (the null every hit must beat) — 7,408 of 7,425 peptide x receptor interfaces folded with ESMFold2 in a single session. One candidate survives: MIMIC. Six independent computational lines of evidence: Interaction — folds a confident interface on IL7R, on the exact surface where interleukin-7 binds (~65% overlap) — co-location with the functional interface, not enrichment. Specificity — picks IL-7Ralpha out of its own gamma-c receptor family, clearing the five closest paralogs; AlphaFold3 agrees independently (two engines, same call). Not a sequence mimic — no sequence homology to IL-7. A structural mimic, not a captured human gene. Mobility — rides a Tcp/ArdA conjugative (Tn916/ICE) element across 239 gut species in two phyla (Bacillota + Actinomycetota), including 15 Clostridioides difficile strains (MGE-enrichment p = 0.003, #2 of 592 families). Conservation across that spread; and 6. alternatives ruled out. Why it matters. Leading hypothesis (of two): MIMIC mutes IL-7 to keep its microbe immune-invisible — a shield the mobile element can trade from commensals into a pathogen like C. difficile. That reframes the microbiome as a mobile library of human-receptor ligands — immune invisibility a microbe can acquire by transfer, not only evolve. Disease stakes are direct (IL-7 immune signaling; C. difficile colitis). Every panel is computational and none measures binding — this is a testable structural hypothesis, and one week settles it: add MIMIC + IL-7 on T cells and read pSTAT5 (suppressed = antagonist/shield; drives it alone = agonist).

Team